MCLE — Medicale Income Statement
0.000.00%
Last trade - 00:00
- $2.08m
- $2.14m
2020 September 30th | 2021 September 30th | R2022 September 30th | 2023 September 30th | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | ||||
Unusual Expense / Income | ||||
Total Operating Expenses | 0.002 | 0.032 | 0.044 | 0.038 |
Operating Profit | -0.002 | -0.032 | -0.044 | -0.038 |
Net Income Before Taxes | -0.002 | -0.032 | -0.044 | -0.038 |
Provision for Income Taxes | ||||
Net Income After Taxes | -0.002 | -0.032 | -0.044 | -0.038 |
Net Income Before Extraordinary Items | ||||
Extraordinary Items | ||||
Net Income | -0.002 | -0.032 | -0.046 | -0.037 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -0.002 | -0.032 | -0.046 | -0.037 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.001 | -0.009 | -0.006 | -0.006 |